𝔖 Bobbio Scriptorium
✦   LIBER   ✦

BCG treatment of malignant pleural effusions in the rat

✍ Scribed by Pimm, M V; Hopper, D G; Baldwin, R W

Book ID
109833522
Publisher
Nature Publishing Group
Year
1976
Tongue
English
Weight
651 KB
Volume
34
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The treatment of malignant pleural effus
The treatment of malignant pleural effusions
✍ Dr. Charles B. Anderson; Gordon W. Philpott; Thomas B. Ferguson πŸ“‚ Article πŸ“… 1974 πŸ› John Wiley and Sons 🌐 English βš– 553 KB
Intrapleural mitoxantrone for the pallia
Intrapleural mitoxantrone for the palliative treatment of malignant pleural effusions
✍ Manuel Morales; Maria del Carmen ExpΓ³sito πŸ“‚ Article πŸ“… 1995 πŸ› Springer-Verlag 🌐 English βš– 230 KB

A group of 21 patients with malignant pleural effusions were treated with the instillation of 40 mg mitoxantrone intrapleurally, after complete fluid drainage. There was a 100% complete response rate with no toxic effects (0%). The mean survival of the patients was 57.1 weeks.

Intracavitary therapy with bleomycin for
Intracavitary therapy with bleomycin for the treatment of malignant pleural effusions
✍ M. J. Ostrowski πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 544 KB

This paper briefly reviews the incidence of malignant pleural effusions (MPE) and the measures that have been used to treat this condition. The role of intracavitary bleomycin in controlling MPE, the doses used, and morbidity associated with its use are reviewed in depth with reference to multicente

Quinacrine in the management of malignan
Quinacrine in the management of malignant pleural effusion
✍ S. A. Taylor; N. S. Hooton; A. M. Macarthur πŸ“‚ Article πŸ“… 1977 πŸ› John Wiley and Sons 🌐 English βš– 209 KB πŸ‘ 2 views

## Abstract Twenty-five patients with malignant pleural effusion were treated with a single intrapleural dose of Quinacrine. Eighteen patients (72 per cent) had a significant response, with no reaccumulation of fluid for at least 2 months following treatment up to a maximum of 18 months in 2 patien